Navigation Links
Novel link between excessive nutrient levels and insulin resistance
Date:2/21/2008

La Jolla, CA For quite some time now, scientists suspected the so-called hexosamine pathway a small side business of the main sugar processing enterprise inside a cell to be involved in the development of insulin resistance. But they could never quite put their finger on the underlying mechanism.

Now, researchers at the Salk Institute for Biological Studies have uncovered the long-missing molecular link: the enzyme OGT (short for O-linked -N-acetylglucosamine transferase), the last in a line of enzymes that shuttle sugars through the hexosamine pathway.

Their study revealed that OGT slams the brake on insulin signaling soon after insulin fires up the machinery that pulls glucose from the blood stream and squirrels it away inside liver or stashes the surplus energy in fat pads.

For the first time we have a real understanding of how the insulin signaling system is turned on and off, says Howard Hughes Medical Investigator Ronald M. Evans, Ph.D., a professor in the Salk Institutes Gene Expression Laboratory, who led the study that appears in the Feb. 21 issue of Nature.

He hopes that this could lead to a new class of insulin-sensitizing drugs that loosen the brake and let insulin work a little bit longer.

When insulin binds its receptor on the cell surface it sets off a cascade of intracellular signals resulting in the production of PIP3, a specialized lipid molecule that masterminds a whole army of molecules that work together to synthesize and store carbohydrates, lipids and proteins. But turning on a physiological process is only half the story, explains Evans. You also need instructions that tell the cell to get off the accelerator and put on the brake.

Postdoctoral researcher and first author Xiaoyong Yang, Ph.D., discovered that PIP3 oversees both. His experiments revealed that within minutes activation of the insulin signaling network coaxes OGT out of the nucleus and into the cytoplasm. It travels
'/>"/>

Contact: Gina Kirchweger
kirchweger@salk.edu
858-453-410-01340
Salk Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Novel organic metal hybrids that will revolutionize materials science and chemical engineering
2. Novel mathematical model predicts new wave of drug-resistant HIV infections in San Francisco
3. Novel approach strips staph of virulence
4. UCSD research team identifies novel anticancer drug from the sea
5. Novel compound may lessen heart attack damage
6. Novel molecules developed at UB can boost vaccine potency
7. Novel small molecule therapy shows benefit for anemic patients via hydration of red blood cells
8. Novel vaccine concept developed by scientists at the Wistar Institute
9. Tibotec Pharmaceuticals a Respectful Partner to HIV Community in Pricing of Novel New HIV NNRTI, INTELENCE
10. Millennium and Harvard Medical School Sign Cooperative Agreement for Research in Novel Field of Cancer Biology
11. Statement by AARP CEO Bill Novelli on President Bushs State of the Union
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...Assembly Member Tom Torlakson Introduces AB 89 , ...ire/ -- Today, Lung Cancer Alliance-California (...lakson (D-11th District) for his continued leaders...or lung cancer research. For the third consecutiv...search is being considered in the California Legis...
(Date:1/8/2009)...pts Prenatal Solution Key Factor in Decision for F...RLANDO, Fla., Jan. 8 All...LLC, one of the largest multi-specialty group prac... the Allscripts Enterprise(TM) Electronic Health R...cians in 18 offices across Central Florida. , ...
(Date:1/8/2009)... St. Jude Children,s Research Hospital have demons...eumonia following influenza. They found that the a...l bacteria by inhibiting their protein synthesis, ...tment with the "beta-lactam" antibiotic ampicillin..., The finding is important because pneumonia, rat...
(Date:1/8/2009)..., Jan. 8 Allscripts-Misy... Healthcare Solutions, Inc. (Allscripts or,the Co...the three and six,months ended November 30, 2008....rnh/20061005/ALLSCRIPTSLOGO-b ) , The Compa...vember 30, 2008,include results from legacy Allsc...
Breaking Medicine News(10 mins):Health News:Lung Cancer Alliance Applauds New Legislation Funding Lung Cancer Research 2Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 2Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 3Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 4Health News:Study finds more effective treatment for pneumonia following influenza 2Health News:Study finds more effective treatment for pneumonia following influenza 3Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 2Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 3Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 4Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 5Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 6Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 7Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 8Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 9Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 10Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 11Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 12Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 13
... from Wake Forest University School of Medicine ha...lar// that reducing injury to the aorta which may... the development of complications to the heart whi... feel by following a technique which reduces injur...
...istwatch invented by South Africa's Gervan Lubbe w...t to be a health hazard. They have warned that the...s diseases like HIV/AIDS.// There are some who hav...an really perform functions like detecting disease...
...y four Marlboro smokers for hi-tech screenings aim... people are demanding that the company pay for spi... were to be brought into force, it will serve to s...etection. The company has been accused of indulgin...
...versity of New South Wales scientists resulted in ...ment can be life threatening and resulted in early...gh because //they identified that the patients who...ffer a progression of the disease, compared with t...
Other Medicine News:Health News:Breaks In The HIV Treatment Resulted In Devastating Results. 2
(Date:1/8/2009)..., UT Southwestern to Identify and Validate Novel...ing with Innovative Gene Expression Platform , ,...- WaferGen Biosystems, Inc. (OTC Bulletin Board: W... expression, genotyping, cell biology and stem cel... a research collaboration with the University of ...
(Date:1/7/2009)..., INDIANAPOLIS, Jan. 7 /PRNewswire-FirstCall...ed today that it received a complete response lett...A) for olanzapine long-acting,injection (LAI) for...in,adults. Lilly is continuing to work with the a... The FDA does not require any additional clinical ...
(Date:1/7/2009)..., First of Several Products in Development Based...ogy to Stimulate Natural BioRegeneration; FDA Fili...TOWN, N.J., Jan. 7 Ost...erging field of biologic products for regenerative...pivotal clinical trial for its DuraTech(TM) BioReg...
(Date:1/6/2009)..., Proves significance of AHCC for maintaining a ...6 A recently published study in N...rs at Kansai Medical University in Osaka, Japan ha...nd) enhances immune function by increasing the num...f the immune system responsible for presenting for...
Breaking Medicine Technology:WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 2WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 3WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 5FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 2FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 3FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 4FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 5FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 6Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 2Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 3Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 2Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 3Online Counseling and Life Coaching Practice Launches New Website 24418 1Online Counseling and Life Coaching Practice Launches New Website 24418 2NYU Langone Medical Centers tip sheet to the International Conference on Alzheimers Disease 2008 4210 1NYU Langone Medical Centers tip sheet to the International Conference on Alzheimers Disease 2008 4210 2NYU Langone Medical Centers tip sheet to the International Conference on Alzheimers Disease 2008 4210 3NYU Langone Medical Centers tip sheet to the International Conference on Alzheimers Disease 2008 4210 4NYU Langone Medical Centers tip sheet to the International Conference on Alzheimers Disease 2008 4210 5NYU Langone Medical Centers tip sheet to the International Conference on Alzheimers Disease 2008 4210 6NYU Langone Medical Centers tip sheet to the International Conference on Alzheimers Disease 2008 4210 7NYU Langone Medical Centers tip sheet to the International Conference on Alzheimers Disease 2008 4210 8BioTrends Releases Quarterly TreatmentTrends 28TM 29 3A Nephrology Report Highlighting Market Trends for Renal Anemia Hyperphosphatemia and Secondar 6748 1BioTrends Releases Quarterly TreatmentTrends 28TM 29 3A Nephrology Report Highlighting Market Trends for Renal Anemia Hyperphosphatemia and Secondar 6748 2BioTrends Releases Quarterly TreatmentTrends 28TM 29 3A Nephrology Report Highlighting Market Trends for Renal Anemia Hyperphosphatemia and Secondar 6748 3Experts to provide peek of Smithsonian soils exhibit 4208 1
... of cancer returning,after surgery for Kit-positiv...OVER, N.J., April 12, 2007 /PRNewswire/ -- Investi...sylate)* tablets to,patients receiving placebo in ...erim analysis showed participants with Kit-positiv...evec following,surgery were significantly less lik...
...,/PRNewswire-FirstCall/ -- Data analyses from the ...m ever undertaken in the renal,anemia arena provid...tional anemia therapy MIRCERA(TM) for the treatmen...isease (CKD) in,patients on dialysis and not on di...National Kidney Foundation 2007 Spring Clinical,Me...
Other Medicine Technology:Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 2Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 3Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 4Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 5Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 6Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 7Data Analyses Outline Efficacy and Safety of Mircera for the,Treatment of Renal Anemia Associated With Chronic Kidney Disease 2Data Analyses Outline Efficacy and Safety of Mircera for the,Treatment of Renal Anemia Associated With Chronic Kidney Disease 3Data Analyses Outline Efficacy and Safety of Mircera for the,Treatment of Renal Anemia Associated With Chronic Kidney Disease 4
... knee prosthesis stems from many years of experien... and manufacturing technologies have been used in ... well as a favorable pressure distribution pattern... a minimum. The inherent design of the components,...
... "Consensus Concept" approach to design by combini...perience of a Scientific Advisory Board. The resul...tate-of-the-art features. Consensus Knee implants ...bility and allow near normal kinematics. The compo...
The major innovations in posterior stabilized (PS) knee design.
The GENESIS II* Total Knee System will define the state of knee implants.
Medicine Products: